Target
Gonadotropin-releasing hormone receptor
Ligand
BDBM160321
Substrate
n/a
Meas. Tech.
FLIPR Calcium Assay
Temperature
310.15±n/a K
IC50
2±n/a nM
Comments
extracted
Citation
 Ohno, KMiyagi, TOzawa, TFushimi, N Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof US Patent  US9040693 Publication Date 5/26/2015 
Target
Name:
Gonadotropin-releasing hormone receptor
Synonyms:
GNRHR | GNRHR_HUMAN | GRHR | GnRH receptor | GnRH-R | Gonadotropin releasing hormone 1 (GnRHR1) | Gonadotropin-releasing hormone receptor | Gonadotropin-releasing hormone receptor (GnRH)
Type:
Enzyme
Mol. Mass.:
37749.45
Organism:
Homo sapiens (Human)
Description:
P30968
Residue:
328
Sequence:
MANSASPEQNQNHCSAINNSIPLMQGNLPTLTLSGKIRVTVTFFLFLLSATFNASFLLKLQKWTQKKEKGKKLSRMKLLLKHLTLANLLETLIVMPLDGMWNITVQWYAGELLCKVLSYLKLFSMYAPAFMMVVISLDRSLAITRPLALKSNSKVGQSMVGLAWILSSVFAGPQLYIFRMIHLADSSGQTKVFSQCVTHCSFSQWWHQAFYNFFTFSCLFIIPLFIMLICNAKIIFTLTRVLHQDPHELQLNQSKNNIPRARLKTLKMTVAFATSFTVCWTPYYVLGIWYWFDPEMLNRLSDPVNHFFFLFAFLNPCFDPLIYGYFSL
  
Inhibitor
Name:
BDBM160321
Synonyms:
US9040693, 22
Type:
Small organic molecule
Emp. Form.:
C22H16ClN3O6S2
Mol. Mass.:
517.962
SMILES:
OC(=O)c1scc2[nH]c(=O)n(-c3cc(ccc3Cl)S(=O)(=O)N3CCCc4ccccc34)c(=O)c12 |(-8.56,-1.78,;-7.02,-1.78,;-6.25,-3.11,;-6.25,-.44,;-7.15,.8,;-6.25,2.05,;-4.78,1.57,;-3.45,2.34,;-2.11,1.57,;-.78,2.34,;-2.11,.03,;-.78,-.74,;.55,.03,;1.89,-.74,;1.89,-2.28,;.55,-3.05,;-.78,-2.28,;-2.11,-3.05,;3.22,.03,;2.45,1.37,;3.99,-1.3,;4.55,.8,;4.55,2.34,;5.89,3.11,;7.22,2.34,;7.22,.8,;8.56,.03,;8.56,-1.51,;7.22,-2.28,;5.89,-1.51,;5.89,.03,;-3.45,-.74,;-3.45,-2.28,;-4.78,.03,)|
Structure:
Search PDB for entries with ligand similarity: